Annual Report 2021
Report by the Board of Directors
Home   >  Report by the Board of Directors  >  2021 in Short  >  Financial Performance in 2021

Financial Performance in January-December 2021

Consolidated statement of comprehensive income, MEUR 2021
2020
  12 months 12 months
     Net sales 86.9 78.4
     Operating profit / loss 3.2 2.1
     Financial income and expenses -0.7 -0.4
     Result before tax 2.5 1.6
Result for the period 3.3 2.2
Total comprehensive income for the period 3.6 1.9
     
Result for the period attributable to:    
     Equity holders of the parent 3.3 2.2
Total comprehensive income for the period attributable to:    
     Equity holders of the parent 3.6 1.9
     
Earnings per share from continuing operations, EUR 0.093 0.061
     


Half Year Figures

Group's net sales and operating result, MEUR  2H/21 1H/21 2H/20 1H/20
Net sales 47.2 39.7 35.8 42.5
Operating profit (loss) 3.9 -0.7 -0.8 2.9
Result before taxes 3.6 -1.0 -0.9 2.5
Result for the period 4.4 -1.0 -0.4 2.5

 
Distribution of net sales by product and services, MEUR and % 2H/21 1H/21 2H/20 1H/20
Product based netsales 35.2
74.5%
27.9
70.3%
23.0
64.3%
30.1
70.7%
Services based net sales 12.0
25.5%
11.8
29.7%
12.8
35.7%
12.5
29.3%

 
Distribution of product-based net sales, MEUR and % 2H/21 1H/21 2H/20 1H/20
Defense & Security products 20.8
59.3%
14.5
51.8%
15.1
65.5%
20.6
68.6%
Medical Technologies products 14.3
40.7%
13.5
48.2%
8.0
34.5%
9.5
31.4%

 
Distribution of services-based net sales, MEUR and % 2H/21 1H/21 2H/20 1H/20
Connectivity Solutions R&D services 7.7
63.8%
7.8
66.6%
8.0
62.4%
7.4
58.9%
Other service-based net sales 4.4
36.2%
3.9
33.4%
4.8
37.6%
5.1
41.1%

 
Distribution of net sales by market areas, MEUR and %  2H/21 1/21 2H/20 1H/20
Asia 0.3
0.6%
0.3
0.6%
0.2
0.5%
0.2
0.4%

Europe
32.0
67.9%
25.0
62.9%
29.3
8.7%
35.2
82.8%

Americas
14.9
31.5%
14.4
36.4%
6.4
17.8%
7.1
16.7%

 
 

Quarterly Figures

Group's net sales and operating result, MEUR  4Q/21 3Q/21 2Q/21 1Q/21 4Q/20
Net sales 30.1 17.1 22.6 17.0 21.8
Operating profit (loss) 3.7 0.2 0.7 -1,5 0.3
Result before taxes 3.5 0.1 0.5 -1.6 0.2
Result for the period 4.3 0.1 0.5 -1.6 0.7

 
Distribution of net sales by product and services, MEUR and % 4Q/21 3Q/21 2Q/21 1Q/21 4Q/20
Product based net sales 23.0
76.5%
12.2
71.0%
16.7
73.8%
11.2
65.7%
14.5
66.5%
Services based net sales 7.1
23.5%
5.0
29.0%
5.9
26.2%
5.9
34.3%
7.3
33.5%

 
Distribution of product-based net sales, MEUR and % 4Q/21 3Q/21 2Q/21 1Q/21 4Q/20
Defense & Security products 15.5
67.6%
5.3
43.4%
11.2
66.8%
3.3
29.5%
10.7
73.6%
Medical Technologies products 7.4
32.4%
6.9
56.6%
5.6
33.2%
7.9
70.5%
3.8
26.4%

 
Distribution of service-based net sales, MEUR and % 4Q/21 3Q/21 2Q/21 1Q/21 4Q/20
Connectivity Solutions R&D services 4.6
64.8%
3.1
62.5%
3.8
63.7%
4.1
69.6%
4.3
58.9%
Other service-based net sales 2.5
35.2%
1.9
37.5%
2.2
36.3%
1.8
30.4%
3.0
41.1%

 
Distribution of net sales by market areas, MEUR and %  4Q/21 3Q/21 2Q/21 1Q/21 4Q/20
Asia 0.2
0.6%
0.1
0.5%
0.1
0.6%
0.1
0.7%
0.1
0.5%

Europe
21.1
70.2%
10.9
63.8%
15.3
67.5%
 9.7
56.9%
18.8
86.2%

Americas
8.8
29.2%
6.1
35.7%
7.2
31.9%
7.2
42.5%
2.9
13.3%

Unless otherwise mentioned, the figures in brackets refer to the corresponding period in the previous year.